These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8415579)

  • 41. Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.
    de Vries C; Veerman H; Nesheim ME; Pannekoek H
    Thromb Haemost; 1991 Mar; 65(3):280-5. PubMed ID: 1904654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
    Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
    Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
    Urano T; deSerrano VS; Urano S; Castellino FJ
    Arch Biochem Biophys; 1989 Apr; 270(1):356-62. PubMed ID: 2494944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elimination of the Cys558-Cys566 bond in Lys78-plasminogen--effect on activation and fibrin interaction.
    Linde V; Nielsen LS; Foster DC; Petersen LC
    Eur J Biochem; 1998 Jan; 251(1-2):472-9. PubMed ID: 9492320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural requirements of position A alpha-157 in fibrinogen for the fibrin-induced rate enhancement of the activation of plasminogen by tissue-type plasminogen activator.
    Schielen JG; Adams HP; Voskuilen M; Tesser GJ; Nieuwenhuizen W
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):655-9. PubMed ID: 1905925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
    Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of plasmin generation by S100A10.
    Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
    Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
    Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH
    Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy.
    Weisel JW; Nagaswami C; Korsholm B; Petersen LC; Suenson E
    J Mol Biol; 1994 Jan; 235(3):1117-35. PubMed ID: 8289311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localization of the binding site of tissue-type plasminogen activator to fibrin.
    Ichinose A; Takio K; Fujikawa K
    J Clin Invest; 1986 Jul; 78(1):163-9. PubMed ID: 3088041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis.
    Tate KM; Higgins DL; Holmes WE; Winkler ME; Heyneker HL; Vehar GA
    Biochemistry; 1987 Jan; 26(2):338-43. PubMed ID: 3103680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
    Higgins DL; Vehar GA
    Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
    Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
    Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C; Veerman H; Blasi F; Pannekoek H
    Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular interactions between tissue-type plasminogen activator and plasminogen.
    Lijnen HR; Collen D
    Methods Enzymol; 1993; 223():197-206. PubMed ID: 8271953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.